Adnexus files for IPO

Adnexus (Waltham, Mass.) filed to raise up to $86.3 million in an IPO underwritten by Lehman; UBS; Cowen; and Lazard. Adnexus plans to begin Phase II testing of Angiocept ( CT-322), a VEGF receptor 2 ...